Artemisinin Antimalarial Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Artemisinin Antimalarial Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Artesunate
Dihydroartemisinin
Artemether
Segment by Application
Prevention
Treatment
Other
By Company
Novartis
Sanofi
Ajanta
Cipla
Ipca
Guilin Medicine
GlaxoSmithKline
Mylan Labs
Roche
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
